Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer
-
Published:2021-07
Issue:1
Volume:222
Page:179-185
-
ISSN:0002-9610
-
Container-title:The American Journal of Surgery
-
language:en
-
Short-container-title:The American Journal of Surgery
Author:
Maruyama TsunehikoORCID,
Shimoda Mitsugi,
Hakoda Hiroyuki,
Sako Akihiro,
Ueda Kazumitsu,
Suzuki Shuji
Subject
General Medicine,Surgery
Reference25 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA oncology,2018
2. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07;Kuebler;J Clin Oncol,2007
3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009
4. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer;Haller;J Clin Oncol,2011
5. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J Clin Oncol,2004
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献